Tapewire

Nasdaq · USD

TELA

TELA Bio, Inc.

Export transactions ↓
Tapewire entity
7381
SEC CIK
0001561921
Parsed reports
268

Last 12 months

Inside the activity.

5 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202620
Sep 202620
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 01, 2023 Filed Jun 2, 2023 20:38 UTC GrantCommon Stock 3,135 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-012779 · form4.xml · nonDerivative · entry 1

O'Brien Federica F. · CIK 0001140119 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,270

F1 · shares: These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 01, 2023 Filed Jun 2, 2023 16:38 UTC GrantStock Option (Right to Buy) · Derivative 5,360 $0.00 Strike: $10.34 $0.00
Disclosure

SEC source: 0001062993-23-012778 · form4.xml · derivative · entry 2

COLLERAN LISA N · CIK 0001212312 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,360

Underlying: Common Stock · 5,360 shares

Expires 2033-06-01

F2 · derivative.exercise_date: The option vests on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 01, 2023 Filed Jun 2, 2023 16:38 UTC GrantCommon Stock 3,135 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-012778 · form4.xml · nonDerivative · entry 1

COLLERAN LISA N · CIK 0001212312 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,270

F1 · shares: These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 01, 2023 Filed Jun 2, 2023 16:37 UTC GrantStock Option (Right to Buy) · Derivative 5,360 $0.00 Strike: $10.34 $0.00
Disclosure

SEC source: 0001062993-23-012777 · form4.xml · derivative · entry 2

EVANS DOUGLAS G · CIK 0001225164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,360

Underlying: Common Stock · 5,360 shares

Expires 2033-06-01

F2 · derivative.exercise_date: The option vests on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 01, 2023 Filed Jun 2, 2023 16:37 UTC GrantCommon Stock 3,135 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-012777 · form4.xml · nonDerivative · entry 1

EVANS DOUGLAS G · CIK 0001225164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,270

F1 · shares: These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 01, 2023 Filed Jun 2, 2023 16:36 UTC GrantStock Option (Right to Buy) · Derivative 5,360 $0.00 Strike: $10.34 $0.00
Disclosure

SEC source: 0001062993-23-012774 · form4.xml · derivative · entry 2

Burgess Vincent J · CIK 0001365408 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,360

Underlying: Common Stock · 5,360 shares

Expires 2033-06-01

F2 · derivative.exercise_date: The option vests on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 01, 2023 Filed Jun 2, 2023 16:36 UTC GrantCommon Stock 3,135 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-012774 · form4.xml · nonDerivative · entry 1

Burgess Vincent J · CIK 0001365408 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,130

F1 · shares: These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 01, 2023 Filed Jun 2, 2023 20:37 UTC GrantStock Option (Right to Buy) · Derivative 5,360 $0.00 Strike: $10.34 $0.00
Disclosure

SEC source: 0001062993-23-012776 · form4.xml · derivative · entry 2

Azarbarzin Kurt · CIK 0001792303 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,360

Underlying: Common Stock · 5,360 shares

Expires 2033-06-01

F2 · derivative.exercise_date: The option vests on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 01, 2023 Filed Jun 2, 2023 20:37 UTC GrantCommon Stock 3,135 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-012776 · form4.xml · nonDerivative · entry 1

Azarbarzin Kurt · CIK 0001792303 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,270

F1 · shares: These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 01, 2023 Filed Jun 2, 2023 20:36 UTC
Nosenzo JohnDirector
GrantStock Option (Right to Buy) · Derivative 5,360 $0.00 Strike: $10.34 $0.00
Disclosure

SEC source: 0001062993-23-012775 · form4.xml · derivative · entry 2

Nosenzo John · CIK 0001835973 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,360

Underlying: Common Stock · 5,360 shares

Expires 2033-06-01

F2 · derivative.exercise_date: The option vests on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 01, 2023 Filed Jun 2, 2023 20:36 UTC
Nosenzo JohnDirector
GrantCommon Stock 3,135 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-012775 · form4.xml · nonDerivative · entry 1

Nosenzo John · CIK 0001835973 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,270

F1 · shares: These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
April 21, 2023 Filed Apr 21, 2023 21:08 UTC SaleCommon Stock 27,700 $9.41 $260,657.00
Disclosure

SEC source: 0000947871-23-000484 · ownership.xml · nonDerivative · entry 3

ORBIMED ADVISORS LLC · CIK 0001055951 · 10% owner

OrbiMed Capital GP IV LLC · CIK 0001502240 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 2,835,542

F1 · ownership.nature: These securities are held of record by OrbiMed Private Investments IV, LP ("OPI IV"). OrbiMed Capital GP IV LLC ("GP IV") is the general partner of OPI IV and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP IV. By virtue of such relationships, OrbiMed Advisors and GP IV may be deemed to have voting power and investment power over the securities held by OPI IV and, as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the securities held by OPI IV.

F2 · ownership.nature: Each of OrbiMed Advisors and GP IV disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any such person or entity, including the Reporting Persons, is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Read SEC document
April 20, 2023 Filed Apr 21, 2023 21:08 UTC SaleCommon Stock 28,300 $9.43 $266,869.00
Disclosure

SEC source: 0000947871-23-000484 · ownership.xml · nonDerivative · entry 2

ORBIMED ADVISORS LLC · CIK 0001055951 · 10% owner

OrbiMed Capital GP IV LLC · CIK 0001502240 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 2,863,242

F1 · ownership.nature: These securities are held of record by OrbiMed Private Investments IV, LP ("OPI IV"). OrbiMed Capital GP IV LLC ("GP IV") is the general partner of OPI IV and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP IV. By virtue of such relationships, OrbiMed Advisors and GP IV may be deemed to have voting power and investment power over the securities held by OPI IV and, as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the securities held by OPI IV.

F2 · ownership.nature: Each of OrbiMed Advisors and GP IV disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any such person or entity, including the Reporting Persons, is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Read SEC document
April 19, 2023 Filed Apr 21, 2023 21:08 UTC SaleCommon Stock 136,000 $9.30 $1,264,800.00
Disclosure

SEC source: 0000947871-23-000484 · ownership.xml · nonDerivative · entry 1

ORBIMED ADVISORS LLC · CIK 0001055951 · 10% owner

OrbiMed Capital GP IV LLC · CIK 0001502240 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 2,891,542

F1 · ownership.nature: These securities are held of record by OrbiMed Private Investments IV, LP ("OPI IV"). OrbiMed Capital GP IV LLC ("GP IV") is the general partner of OPI IV and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP IV. By virtue of such relationships, OrbiMed Advisors and GP IV may be deemed to have voting power and investment power over the securities held by OPI IV and, as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the securities held by OPI IV.

F2 · ownership.nature: Each of OrbiMed Advisors and GP IV disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any such person or entity, including the Reporting Persons, is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 18:01 UTC
Talmo PaulChief Strategic Officer
Tax withholdingCommon Stock 187 $10.64 $1,989.68
Disclosure

SEC source: 0001062993-23-008665 · form4.xml · nonDerivative · entry 1

Talmo Paul · CIK 0001899089 · Chief Strategic Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,976

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 18:02 UTC
Murphy Peter C.Chief Commercial Officer
Tax withholdingCommon Stock 163 $10.64 $1,734.32
Disclosure

SEC source: 0001062993-23-008666 · form4.xml · nonDerivative · entry 1

Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,987

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 18:03 UTC
KOBLISH ANTONYDirector · Chief Executive Officer
Tax withholdingCommon Stock 385 $10.64 $4,096.40
Disclosure

SEC source: 0001062993-23-008668 · form4.xml · nonDerivative · entry 1

KOBLISH ANTONY · CIK 0001195881 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 292,634

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 22:03 UTC
Smeykal MeganChief Accounting Officer · Controller
Tax withholdingCommon Stock 96 $10.64 $1,021.44
Disclosure

SEC source: 0001062993-23-008667 · form4.xml · nonDerivative · entry 1

Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,431

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
March 29, 2023 Filed Mar 31, 2023 16:32 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 4,860 $0.00 Strike: $4.44 $0.00
Disclosure

SEC source: 0001062993-23-008208 · form4.xml · derivative · entry 2

Burgess Vincent J · CIK 0001365408 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,860 shares

Expires 2023-04-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 29, 2023 Filed Mar 31, 2023 16:32 UTC Exercise / conversionCommon Stock 4,860 $4.44 $21,578.40
Disclosure

SEC source: 0001062993-23-008208 · form4.xml · nonDerivative · entry 1

Burgess Vincent J · CIK 0001365408 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,995

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 24, 2023 Filed Feb 27, 2023 19:18 UTC
Talmo PaulChief Strategic Officer
Tax withholdingCommon Stock 1,032 $11.03 $11,382.96
Disclosure

SEC source: 0001062993-23-005026 · form4.xml · nonDerivative · entry 3

Talmo Paul · CIK 0001899089 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,163

F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.

Read SEC document
February 24, 2023 Filed Feb 27, 2023 19:19 UTC
Murphy Peter C.Chief Commercial Officer
Tax withholdingCommon Stock 940 $11.03 $10,368.20
Disclosure

SEC source: 0001062993-23-005027 · form4.xml · nonDerivative · entry 3

Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,150

F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.

Read SEC document
February 24, 2023 Filed Feb 27, 2023 19:16 UTC
KOBLISH ANTONYChief Executive Officer
Tax withholdingCommon Stock 6,034 $11.03 $66,555.02
Disclosure

SEC source: 0001062993-23-005025 · form4.xml · nonDerivative · entry 2

KOBLISH ANTONY · CIK 0001195881 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 293,019

F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.

Read SEC document
February 24, 2023 Filed Feb 28, 2023 00:14 UTC
Smeykal MeganChief Accounting Officer · Controller
Tax withholdingCommon Stock 539 $11.03 $5,945.17
Disclosure

SEC source: 0001062993-23-005024 · form4.xml · nonDerivative · entry 2

Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,527

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 19:18 UTC
Talmo PaulChief Strategic Officer
GrantStock Option (Right to Buy) · Derivative 26,400 $0.00 Strike: $10.50 $0.00
Disclosure

SEC source: 0001062993-23-005026 · form4.xml · derivative · entry 4

Talmo Paul · CIK 0001899089 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,400

Underlying: Common Stock · 26,400 shares

Expires 2033-02-23

F3 · derivative.exercise_date: The option vests 25% on February 23, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 19:18 UTC
Talmo PaulChief Strategic Officer
Tax withholdingCommon Stock 1,067 $10.50 $11,203.50
Disclosure

SEC source: 0001062993-23-005026 · form4.xml · nonDerivative · entry 2

Talmo Paul · CIK 0001899089 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,195

F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 19:18 UTC
Talmo PaulChief Strategic Officer
GrantCommon Stock 16,800 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-005026 · form4.xml · nonDerivative · entry 1

Talmo Paul · CIK 0001899089 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,262

F1 · shares: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 19:19 UTC
Murphy Peter C.Chief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 26,400 $0.00 Strike: $10.50 $0.00
Disclosure

SEC source: 0001062993-23-005027 · form4.xml · derivative · entry 4

Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,400

Underlying: Common Stock · 26,400 shares

Expires 2033-02-23

F3 · derivative.exercise_date: The option vests 25% on February 23, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 19:19 UTC
Murphy Peter C.Chief Commercial Officer
Tax withholdingCommon Stock 906 $10.50 $9,513.00
Disclosure

SEC source: 0001062993-23-005027 · form4.xml · nonDerivative · entry 2

Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,090

F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 19:19 UTC
Murphy Peter C.Chief Commercial Officer
GrantCommon Stock 16,800 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-005027 · form4.xml · nonDerivative · entry 1

Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,996

F1 · shares: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 19:16 UTC
KOBLISH ANTONYChief Executive Officer
GrantStock Option (Right to Buy) · Derivative 96,100 $0.00 Strike: $10.50 $0.00
Disclosure

SEC source: 0001062993-23-005025 · form4.xml · derivative · entry 3

KOBLISH ANTONY · CIK 0001195881 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,100

Underlying: Common Stock · 96,100 shares

Expires 2033-02-23

F3 · derivative.exercise_date: The option vests 25% on February 23, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 19:16 UTC
KOBLISH ANTONYChief Executive Officer
GrantCommon Stock 61,200 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-005025 · form4.xml · nonDerivative · entry 1

KOBLISH ANTONY · CIK 0001195881 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 299,053

F1 · shares: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates.

Read SEC document
February 23, 2023 Filed Feb 28, 2023 00:20 UTC
Cuca RobertoCOO and CFO
GrantStock Option (Right to Buy) · Derivative 27,700 $0.00 Strike: $10.50 $0.00
Disclosure

SEC source: 0001062993-23-005028 · form4.xml · derivative · entry 3

Cuca Roberto · CIK 0001591474 · COO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,700

Underlying: Common Stock · 27,700 shares

Expires 2033-02-23

F3 · derivative.exercise_date: The option vests 25% on February 23, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.

Read SEC document
February 23, 2023 Filed Feb 28, 2023 00:20 UTC
Cuca RobertoCOO and CFO
Tax withholdingCommon Stock 1,300 $10.50 $13,650.00
Disclosure

SEC source: 0001062993-23-005028 · form4.xml · nonDerivative · entry 2

Cuca Roberto · CIK 0001591474 · COO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,292

F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.

Read SEC document
February 23, 2023 Filed Feb 28, 2023 00:20 UTC
Cuca RobertoCOO and CFO
GrantCommon Stock 17,700 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-005028 · form4.xml · nonDerivative · entry 1

Cuca Roberto · CIK 0001591474 · COO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,592

F1 · shares: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates.

Read SEC document
February 23, 2023 Filed Feb 28, 2023 00:14 UTC
Smeykal MeganChief Accounting Officer · Controller
Tax withholdingCommon Stock 423 $10.50 $4,441.50
Disclosure

SEC source: 0001062993-23-005024 · form4.xml · nonDerivative · entry 1

Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,066

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
February 21, 2023 Filed Feb 23, 2023 21:10 UTC
Smeykal MeganChief Accounting Officer · Controller
GrantCommon Stock 9,400 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-004533 · form4.xml · nonDerivative · entry 1

Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,489

F1 · shares: These restricted stock units will vest in four equal annual installments beginning on February 21, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates.

Read SEC document
November 03, 2022 Filed Nov 4, 2022 20:03 UTC PurchaseCommon Stock, par value $0.001 per share 1,262 $7.81 $9,858.62
Disclosure

SEC source: 0001493152-22-030666 · ownership.xml · nonDerivative · entry 2

Opaleye Management Inc. · CIK 0001595855 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Managed Account

Disclosed balance after: 124,813

F3 · price: This transaction was executed in multiple trades at prices ranging from $7.76 to $7.85; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased.

F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.

Read SEC document
November 03, 2022 Filed Nov 4, 2022 20:03 UTC PurchaseCommon Stock, par value $0.001 per share 19,000 $7.81 $148,426.10
Disclosure

SEC source: 0001493152-22-030666 · ownership.xml · nonDerivative · entry 1

Opaleye Management Inc. · CIK 0001595855 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Opaleye, L.P.

Disclosed balance after: 1,948,000

F3 · price: This transaction was executed in multiple trades at prices ranging from $7.76 to $7.85; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased.

F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.

Read SEC document
October 11, 2022 Filed Oct 11, 2022 23:29 UTC PurchaseCommon Stock, par value $0.001 per share 1,000 $8.00 $8,000.00
Disclosure

SEC source: 0001493152-22-028176 · ownership.xml · nonDerivative · entry 2

Opaleye Management Inc. · CIK 0001595855 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Managed Account

Disclosed balance after: 123,551

F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.

Read SEC document
October 11, 2022 Filed Oct 11, 2022 23:29 UTC PurchaseCommon Stock, par value $0.001 per share 15,000 $8.00 $120,000.00
Disclosure

SEC source: 0001493152-22-028176 · ownership.xml · nonDerivative · entry 1

Opaleye Management Inc. · CIK 0001595855 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Opaleye, L.P.

Disclosed balance after: 1,929,000

F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.

Read SEC document
September 23, 2022 Filed Sep 26, 2022 20:05 UTC PurchaseCommon Stock, par value $0.001 per share 304 $7.99 $2,430.24
Disclosure

SEC source: 0001493152-22-026798 · ownership.xml · nonDerivative · entry 2

Opaleye Management Inc. · CIK 0001595855 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Managed Account

Disclosed balance after: 122,551

F3 · price: This transaction was executed in multiple trades at prices ranging from $7.9804 to $8.00; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased.

F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.

Read SEC document
September 23, 2022 Filed Sep 26, 2022 20:05 UTC PurchaseCommon Stock, par value $0.001 per share 6,500 $7.99 $51,962.30
Disclosure

SEC source: 0001493152-22-026798 · ownership.xml · nonDerivative · entry 1

Opaleye Management Inc. · CIK 0001595855 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Opaleye, L.P.

Disclosed balance after: 1,914,000

F3 · price: This transaction was executed in multiple trades at prices ranging from $7.9804 to $8.00; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased.

F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.

Read SEC document
September 19, 2022 Filed Sep 19, 2022 23:27 UTC PurchaseCommon Stock, par value $0.001 per share 1,000 $8.09 $8,088.00
Disclosure

SEC source: 0001493152-22-026276 · ownership.xml · nonDerivative · entry 2

Opaleye Management Inc. · CIK 0001595855 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Managed Account

Disclosed balance after: 122,247

F3 · price: This transaction was executed in multiple trades at prices ranging from $8.0873 to $8.09; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased.

F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.

Read SEC document
September 19, 2022 Filed Sep 19, 2022 23:27 UTC PurchaseCommon Stock, par value $0.001 per share 17,000 $8.09 $137,496.00
Disclosure

SEC source: 0001493152-22-026276 · ownership.xml · nonDerivative · entry 1

Opaleye Management Inc. · CIK 0001595855 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Opaleye, L.P.

Disclosed balance after: 1,907,500

F3 · price: This transaction was executed in multiple trades at prices ranging from $8.0873 to $8.09; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased.

F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.

Read SEC document
September 16, 2022 Filed Sep 16, 2022 21:47 UTC PurchaseCommon Stock, par value $0.001 per share 372 $8.08 $3,006.91
Disclosure

SEC source: 0001493152-22-026144 · ownership.xml · nonDerivative · entry 4

Opaleye Management Inc. · CIK 0001595855 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Managed Account

Disclosed balance after: 121,247

F3 · price: This transaction was executed in multiple trades at prices ranging from $8.0786 to $8.085; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased.

F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.

Read SEC document
September 16, 2022 Filed Sep 16, 2022 21:47 UTC PurchaseCommon Stock, par value $0.001 per share 2,000 $8.08 $16,166.20
Disclosure

SEC source: 0001493152-22-026144 · ownership.xml · nonDerivative · entry 3

Opaleye Management Inc. · CIK 0001595855 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Opaleye, L.P.

Disclosed balance after: 1,890,500

F3 · price: This transaction was executed in multiple trades at prices ranging from $8.0786 to $8.085; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased.

F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.

Read SEC document
September 15, 2022 Filed Sep 16, 2022 21:47 UTC PurchaseCommon Stock, par value $0.001 per share 658 $8.10 $5,329.80
Disclosure

SEC source: 0001493152-22-026144 · ownership.xml · nonDerivative · entry 2

Opaleye Management Inc. · CIK 0001595855 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Managed Account

Disclosed balance after: 120,875

F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.

Read SEC document
September 15, 2022 Filed Sep 16, 2022 21:47 UTC PurchaseCommon Stock, par value $0.001 per share 3,500 $8.10 $28,350.00
Disclosure

SEC source: 0001493152-22-026144 · ownership.xml · nonDerivative · entry 1

Opaleye Management Inc. · CIK 0001595855 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Opaleye, L.P.

Disclosed balance after: 1,888,500

F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 16:07 UTC
EW HEALTHCARE PARTNERS FUND 2-A, L.P.10% owner · See footnote 2
PurchaseCommon Stock, par value $0.001 per share 500,000 $8.00 $4,000,000.00
Disclosure

SEC source: 0000899243-22-029273 · doc4.xml · nonDerivative · entry 1

EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2

EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See footnote 2

EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner

EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 4,105,709

F1 · ownership.nature: The share total shown above is the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 196,483 shares of the amount shown above and Fund 2-A purchased 303,517 shares of the amount shown above. Fund 2 now holds a total of 1,630,994 shares and Fund 2-A now holds a total of 2,474,715 shares of the Issuer.

F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.